Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TIROFIBAN HYDROCHLORIDE
(1998)
Small molecule
Integrin alpha-IIb/beta-3 inhibitor
INJECTION
Approved
Myocardial Infarction
TIROFIBAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
6H925F8O5J
Molecule Type:
Small molecule
Molecular Formula:
C22H39ClN2O6S
Molecular Weight:
495.08
AlogP:
2.95
PSA:
104.73
HBD:
3.0
HBA:
#RotB:
14.0
Source:
CANDESARTAN CILEXETIL
(1998)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Angina Pectoris; Cardiovascular Diseases; Diabetes Mellitus; Heart Failure; Hypertension; Myocardial Infarction; Stroke
CANDESARTAN CILEXETIL
×
Maximum Phase:
4
First Approval:
1998
UNII:
R85M2X0D68
Molecule Type:
Small molecule
Molecular Formula:
C33H34N6O6
Molecular Weight:
610.67
AlogP:
6.32
PSA:
143.34
HBD:
1.0
HBA:
#RotB:
10.0
Source:
SEVELAMER HYDROCHLORIDE
(1998)
Small molecule
Phosphate sequestering agent
ORAL
Approved
Unknown
SEVELAMER HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
GLS2PGI8QG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEFLUNOMIDE
(1998)
Small molecule
Dihydroorotate dehydrogenase inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases; Multiple Sclerosis
LEFLUNOMIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
G162GK9U4W
Molecule Type:
Small molecule
Molecular Formula:
C12H9F3N2O2
Molecular Weight:
270.21
AlogP:
3.25
PSA:
55.13
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TOLTERODINE TARTRATE
(1998)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
ORAL
Approved
Urinary Bladder, Overactive; Urinary Incontinence, Urge
TOLTERODINE TARTRATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
5T619TQR3R
Molecule Type:
Small molecule
Molecular Formula:
C26H37NO7
Molecular Weight:
475.58
AlogP:
5.34
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
7.0
Source:
LOTEPREDNOL ETABONATE
(1998)
Small molecule
Glucocorticoid receptor agonist
OPHTHALMIC
Approved
Conjunctivitis, Allergic; Dry Eye Syndromes; Eye Diseases; Inflammation; Uveitis, Anterior
LOTEPREDNOL ETABONATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
YEH1EZ96K6
Molecule Type:
Small molecule
Molecular Formula:
C24H31ClO7
Molecular Weight:
466.96
AlogP:
3.92
PSA:
99.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SIMETHICONE-CELLULOSE
(1998)
Small molecule
Unknown
ORAL
Approved
Unknown
SIMETHICONE-CELLULOSE
×
Maximum Phase:
4
First Approval:
1998
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABACAVIR
(1998)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
ABACAVIR
×
Maximum Phase:
4
First Approval:
1998
UNII:
WR2TIP26VS
Molecule Type:
Small molecule
Molecular Formula:
C14H18N6O
Molecular Weight:
286.34
AlogP:
1.09
PSA:
101.88
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TOLCAPONE
(1998)
Small molecule
Catechol O-methyltransferase inhibitor
ORAL
Approved
Liver Failure; Parkinson Disease
TOLCAPONE
×
Maximum Phase:
4
First Approval:
1998
UNII:
CIF6334OLY
Molecule Type:
Small molecule
Molecular Formula:
C14H11NO5
Molecular Weight:
273.24
AlogP:
2.55
PSA:
100.67
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TOLTERODINE
(1998)
Small molecule
Unknown
Unknown
Approved
Polyuria; Urinary Incontinence
TOLTERODINE
×
Maximum Phase:
4
First Approval:
1998
UNII:
WHE7A56U7K
Molecule Type:
Small molecule
Molecular Formula:
C22H31NO
Molecular Weight:
325.5
AlogP:
5.34
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TELMISARTAN
(1998)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Cardiovascular Diseases; Diabetes Mellitus; Hypertension; Myocardial Infarction; Stroke
TELMISARTAN
×
Maximum Phase:
4
First Approval:
1998
UNII:
U5SYW473RQ
Molecule Type:
Small molecule
Molecular Formula:
C33H30N4O2
Molecular Weight:
514.63
AlogP:
7.26
PSA:
72.94
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CITALOPRAM
(1998)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
CITALOPRAM
×
Maximum Phase:
4
First Approval:
1998
UNII:
0DHU5B8D6V
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN2O
Molecular Weight:
324.4
AlogP:
3.81
PSA:
36.26
HBD:
0.0
HBA:
#RotB:
5.0
Source:
SILDENAFIL CITRATE
(1998)
Small molecule
Phosphodiesterase 5A inhibitor
INTRAVENOUS; ORAL
Approved
Connective Tissue Diseases; Erectile Dysfunction; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Pulmonary Arterial Hypertension
SILDENAFIL CITRATE
×
Maximum Phase:
4
First Approval:
1998
UNII:
BW9B0ZE037
Molecule Type:
Small molecule
Molecular Formula:
C28H38N6O11S
Molecular Weight:
666.71
AlogP:
1.61
PSA:
113.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
RIFAPENTINE
(1998)
Small molecule
Bacterial DNA-directed RNA polymerase inhibitor
ORAL
Approved
Tuberculosis
RIFAPENTINE
×
Maximum Phase:
4
First Approval:
1998
UNII:
XJM390A33U
Molecule Type:
Small molecule
Molecular Formula:
C47H64N4O12
Molecular Weight:
877.04
AlogP:
5.65
PSA:
220.15
HBD:
6.0
HBA:
#RotB:
5.0
Source:
NARATRIPTAN HYDROCHLORIDE
(1998)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
NARATRIPTAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1998
UNII:
10X8X4P12Z
Molecule Type:
Small molecule
Molecular Formula:
C17H26ClN3O2S
Molecular Weight:
371.93
AlogP:
2.07
PSA:
65.2
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PARICALCITOL
(1998)
Small molecule
Vitamin D receptor agonist
INJECTION; INTRAVENOUS; ORAL
Approved
Hyperparathyroidism, Secondary; Parathyroid Diseases; Renal Insufficiency, Chronic
PARICALCITOL
×
Maximum Phase:
4
First Approval:
1998
UNII:
6702D36OG5
Molecule Type:
Small molecule
Molecular Formula:
C27H44O3
Molecular Weight:
416.65
AlogP:
5.56
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
5.0
Source:
RISEDRONIC ACID
(1998)
Small molecule
Unknown
Unknown
Approved
Bone Diseases
RISEDRONIC ACID
×
Maximum Phase:
4
First Approval:
1998
UNII:
KM2Z91756Z
Molecule Type:
Small molecule
Molecular Formula:
C7H11NO7P2
Molecular Weight:
283.11
AlogP:
-0.37
PSA:
148.18
HBD:
5.0
HBA:
#RotB:
4.0
Source:
LEVOSALBUTAMOL
(1999)
Small molecule
Unknown
Unknown
Approved
Unknown
LEVOSALBUTAMOL
×
Maximum Phase:
4
First Approval:
1999
UNII:
EDN2NBH5SS
Molecule Type:
Small molecule
Molecular Formula:
C13H21NO3
Molecular Weight:
239.31
AlogP:
1.31
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
4.0
Source:
ZALEPLON
(1999)
Small molecule
GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator
ORAL
Approved
Sleep Initiation and Maintenance Disorders
ZALEPLON
×
Maximum Phase:
4
First Approval:
1999
UNII:
S62U433RMH
Molecule Type:
Small molecule
Molecular Formula:
C17H15N5O
Molecular Weight:
305.34
AlogP:
2.64
PSA:
74.29
HBD:
0.0
HBA:
#RotB:
3.0
Source:
RABEPRAZOLE
(1999)
Small molecule
Unknown
Unknown
Approved
Gastroesophageal Reflux; Peptic Ulcer
RABEPRAZOLE
×
Maximum Phase:
4
First Approval:
1999
UNII:
32828355LL
Molecule Type:
Small molecule
Molecular Formula:
C18H21N3O3S
Molecular Weight:
359.45
AlogP:
2.99
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ROFECOXIB
(1999)
Small molecule
Cyclooxygenase-2 inhibitor
ORAL
Approved
Rheumatic Diseases
ROFECOXIB
×
Maximum Phase:
4
First Approval:
1999
UNII:
0QTW8Z7MCR
Molecule Type:
Small molecule
Molecular Formula:
C17H14O4S
Molecular Weight:
314.36
AlogP:
2.56
PSA:
60.44
HBD:
0.0
HBA:
#RotB:
3.0
Source:
DOXERCALCIFEROL
(1999)
Small molecule
Vitamin D receptor agonist
INJECTION; ORAL
Approved
Hyperparathyroidism, Secondary; Parathyroid Diseases; Renal Insufficiency, Chronic
DOXERCALCIFEROL
×
Maximum Phase:
4
First Approval:
1999
UNII:
3DIZ9LF5Y9
Molecule Type:
Small molecule
Molecular Formula:
C28H44O2
Molecular Weight:
412.66
AlogP:
6.61
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GATIFLOXACIN
(1999)
Small molecule
DNA gyrase inhibitor
OPHTHALMIC
Approved
Bacterial Infections; Conjunctivitis, Bacterial; Eye Infections; Infections
GATIFLOXACIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
81485Y3A9A
Molecule Type:
Small molecule
Molecular Formula:
C19H22FN3O4
Molecular Weight:
375.4
AlogP:
1.98
PSA:
83.8
HBD:
2.0
HBA:
#RotB:
4.0
Source:
LEVALBUTEROL HYDROCHLORIDE
(1999)
Small molecule
Beta-2 adrenergic receptor agonist
INHALATION
Approved
Bronchial Spasm
LEVALBUTEROL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
WDQ1526QJM
Molecule Type:
Small molecule
Molecular Formula:
C13H22ClNO3
Molecular Weight:
275.78
AlogP:
1.31
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
4.0
Source:
EPIRUBICIN
(1999)
Small molecule
Unknown
Unknown
Approved
Neoplasms
EPIRUBICIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
3Z8479ZZ5X
Molecule Type:
Small molecule
Molecular Formula:
C27H29NO11
Molecular Weight:
543.53
AlogP:
0.0
PSA:
206.07
HBD:
6.0
HBA:
#RotB:
5.0
Source:
LEVOBUPIVACAINE
(1999)
Small molecule
Unknown
Unknown
Approved
Unknown
LEVOBUPIVACAINE
×
Maximum Phase:
4
First Approval:
1999
UNII:
A5H73K9U3W
Molecule Type:
Small molecule
Molecular Formula:
C18H28N2O
Molecular Weight:
288.44
AlogP:
3.9
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CILOSTAZOL
(1999)
Small molecule
Phosphodiesterase 3A inhibitor
ORAL
Approved
Thrombosis
CILOSTAZOL
×
Maximum Phase:
4
First Approval:
1999
UNII:
N7Z035406B
Molecule Type:
Small molecule
Molecular Formula:
C20H27N5O2
Molecular Weight:
369.47
AlogP:
3.46
PSA:
81.93
HBD:
1.0
HBA:
#RotB:
7.0
Source:
LEVOBUPIVACAINE HYDROCHLORIDE
(1999)
Small molecule
Sodium channel protein type IV alpha subunit blocker
Unknown
Approved
Unknown
LEVOBUPIVACAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
J998RDZ51I
Molecule Type:
Small molecule
Molecular Formula:
C18H29ClN2O
Molecular Weight:
324.9
AlogP:
3.9
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
GADOVERSETAMIDE
(1999)
Small molecule
Diagnostic agent
INJECTION
Approved
Unknown
GADOVERSETAMIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
RLM74T3Z9D
Molecule Type:
Small molecule
Molecular Formula:
C20H34GdN5O10
Molecular Weight:
661.77
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
EXEMESTANE
(1999)
Small molecule
Cytochrome P450 19A1 inhibitor
Unknown
Approved
Breast Neoplasms; Neoplasms
EXEMESTANE
×
Maximum Phase:
4
First Approval:
1999
UNII:
NY22HMQ4BX
Molecule Type:
Small molecule
Molecular Formula:
C20H24O2
Molecular Weight:
296.41
AlogP:
4.03
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
0.0
Source:
RABEPRAZOLE SODIUM
(1999)
Small molecule
Potassium-transporting ATPase inhibitor
Unknown
Approved
Duodenal Ulcer; Gastroesophageal Reflux; Zollinger-Ellison Syndrome
RABEPRAZOLE SODIUM
×
Maximum Phase:
4
First Approval:
1999
UNII:
3L36P16U4R
Molecule Type:
Small molecule
Molecular Formula:
C18H20N3NaO3S
Molecular Weight:
381.43
AlogP:
2.99
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DEXMEDETOMIDINE HYDROCHLORIDE
(1999)
Small molecule
Adrenergic receptor alpha-2 agonist
INJECTION; INTRAVENOUS
Approved
Unknown
DEXMEDETOMIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
1018WH7F9I
Molecule Type:
Small molecule
Molecular Formula:
C13H17ClN2
Molecular Weight:
236.75
AlogP:
3.18
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MOXIFLOXACIN HYDROCHLORIDE
(1999)
Small molecule
Bacterial DNA gyrase inhibitor
INTRAVENOUS; OPHTHALMIC; ORAL
Approved
Bronchitis, Chronic; Conjunctivitis, Bacterial; Infections; Pneumonia; Sinusitis
MOXIFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
C53598599T
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClFN3O4
Molecular Weight:
437.9
AlogP:
2.37
PSA:
83.8
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ALITRETINOIN
(1999)
Small molecule
Retinoid receptor agonist
TOPICAL
Approved
Eczema; Neoplasms
ALITRETINOIN
×
Maximum Phase:
4
First Approval:
1999
UNII:
1UA8E65KDZ
Molecule Type:
Small molecule
Molecular Formula:
C20H28O2
Molecular Weight:
300.44
AlogP:
5.6
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PIOGLITAZONE HYDROCHLORIDE
(1999)
Small molecule
Peroxisome proliferator-activated receptor gamma agonist
ORAL
Approved
Diabetes Mellitus, Type 2; Liver Diseases
PIOGLITAZONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1999
UNII:
JQT35NPK6C
Molecule Type:
Small molecule
Molecular Formula:
C19H21ClN2O3S
Molecular Weight:
392.91
AlogP:
3.16
PSA:
68.29
HBD:
1.0
HBA:
#RotB:
7.0
Source:
KETOTIFEN
(1999)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Hypersensitivity
KETOTIFEN
×
Maximum Phase:
4
First Approval:
1999
UNII:
X49220T18G
Molecule Type:
Small molecule
Molecular Formula:
C19H19NOS
Molecular Weight:
309.43
AlogP:
4.01
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
0.0
Source:
1
2
…
48
49
50
51
52
53
54
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA